Charlotte C.
- Country
- France
- Department
- Unité Neuro Vasculaire
Research Overview
- Efficacy of prophylactic levetiracetam on functional outcomes in patients with acute intracerebral haemorrhage: a phase 3, randomised, double-blind, placebo-controlled trial
- Efficacy of Apixaban Versus Standard Care in Patients with Intracerebral Hemorrhage: A Randomized Controlled Trial
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Asundexian for Ischemic Stroke Prevention in Adults Post-Acute Non-Cardioembolic Stroke or High-Risk TIA
Data & Insights
Has run more than one trial at 47 of 328 partner sites.
Specializations
Cerebrovascular Disorders
This investigator specializes in treating and studying intracerebral hemorrhage and its various manifestations, with particular attention to innovative therapeutic approaches in acute cerebral bleeding management.
- Spontaneous intracerebral hemorrhage treatment
- Acute stroke management
- Blood-related complications in brain tissue
Their research encompasses hemorrhagic stroke interventions and preventive strategies.
Stroke Prevention
The investigator focuses on developing strategies for ischemic stroke prevention, particularly in patients who have experienced previous cerebrovascular events.
- Post-stroke anticoagulation strategies
- Transient ischemic attack management
- Non-cardioembolic stroke treatment
Their work includes evaluation of anticoagulation approaches in high-risk patients.
Therapeutic Innovations
The investigator explores novel therapeutic agents including tranexamic acid and emerging anticoagulants for cerebrovascular conditions.
- Novel anticoagulation therapies
- Hemorrhage control medications
- Clinical outcomes assessment
Their research evaluates both established and experimental treatments for stroke prevention and management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.